Clinical Trial

A Study on Remote Health Support for Patients With Heart Failure.

Study acronym: RAPHAEL
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 27, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This multicenter prospective observational feasibility study evaluates the implementation of the RAPHAEL model, a remote monitoring palliative care approach for patients with heart failure. The study aims to assess the feasibility, acceptability, usability, and implementation outcomes of integrating structured remote symptom monitoring and palliative care needs assessment into routine outpatient heart failure care. Adult patients with heart failure and worsening symptoms and/or potential palliative care needs will complete a structured digital questionnaire during a 4-week follow-up period. Healthcare professionals will review reported needs and conduct follow-up contact according to usual clinical practice. No experimental drugs or devices are administered, and clinical management remains at the discretion of the treating team. Primary outcomes focus on feasibility and implementation metrics, including participation rates, acceptability, usability, perceived burden, resource requirements, fidelity to the intervention model, training adoption, applicability, adaptation, and demand.
Trial Details
NCT Number NCT07440472
Lead Sponsor Universitat Internacional de Catalunya
Collaborators: Università degli Studi di Brescia, Linkoeping University, University College London Hospitals, European Association for Palliative Care, Centre Hospitalier Universitaire Vaudois, University of Leeds, Maastricht University Medical Center, University of Humanistic Studies, Althaia Xarxa Assistencial Universitària de Manresa, IRIS-CC, University of Vic - Central University of Catalonia, University Hospital, Aachen, Wroclaw Medical University, UMC Utrecht, Vilnius University
Conditions Heart Failure
Enrollment 90 participants
Start Date 2026-03
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-02-27